carbamazepine has been researched along with Schizophrenia in 142 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole were studied in 18 inpatients with schizophrenia being treated with aripiprazole." | 9.14 | Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia. ( Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Suzuki, T, 2009) |
| "Based on currently available randomised trial-derived evidence, carbamazepine cannot be recommended for routine clinical use for treatment or augmentation of antipsychotic treatment of schizophrenia." | 8.90 | Carbamazepine for schizophrenia. ( Dold, M; Helfer, B; Kissling, W; Leucht, S; McGrath, J, 2014) |
| "To evaluate the effects of carbamazepine and its derivatives for the treatment of schizophrenia and related psychoses." | 8.84 | Carbamazepine for schizophrenia. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2007) |
| "Based on currently available evidence from randomised trials, carbamazepine cannot be recommend for routine clinical use for sole treatment, or augmentation of antipsychotic treatment, of schizophrenia." | 8.81 | Carbamazepine for schizophrenia and schizoaffective psychoses. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2002) |
| "Randomized controlled trials comparing carbamazepine (as a sole or as an adjunctive compound) with placebo or no intervention in participants with schizophrenia or schizoaffective disorder were searched for by accessing 7 electronic databases, cross-referencing publications cited in pertinent studies, and contacting drug companies that manufacture carbamazepine." | 8.81 | Carbamazepine augmentation for schizophrenia: how good is the evidence? ( Kissling, W; Leucht, S; McGrath, J; White, P, 2002) |
| "Based on currently available randomised trial-derived evidence, carbamazepine cannot be recommend for routine clinical use for treatment or augmentation of antipsychotic treatment of schizophrenia." | 8.80 | Carbamazepine for schizophrenia and schizoaffective psychoses. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2000) |
| "We report the case of a 61-year-old man with schizophrenia who was treated with carbamazepine, in whom electrocardiography showed transient Brugada-type ST elevation." | 7.85 | A Carbamazepine-induced Brugada-type Electrocardiographic Pattern in a Patient with Schizophrenia. ( Hasebe, N; Kawamura, Y; Ota, H; Sato, N, 2017) |
| " Perazine in combination with carbamazepine has shown satisfying results in several single-schizophrenia patients, leading to the hypothesis of being equal or even superior to atypical antipsychotic monotherapy." | 7.74 | Perazine and carbamazepine in comparison to olanzapine in schizophrenia. ( Emrich, HM; Godecke-Koch, T; Hoffmann, J; Jahn, K; Ohlmeier, MD; Schneider, U; Seifert, J; Wilhelm-Gossling, C, 2007) |
| "An autopsy case of carbamazepine overdose with focal myocarditis is reported." | 7.73 | A case of carbamazepine overdose with focal myocarditis. ( Aoki, Y; Niitsu, H; Saigusa, K; Takamiya, M, 2006) |
| "The efficacy of an adjuvant application of carbamazepine in cannabis-related schizophrenia-like psychosis not responsive to neuroleptic treatment is reported for the first time." | 7.70 | Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse. ( Emrich, HM; Leweke, FM, 1999) |
| "We described a 29-year-old Japanese woman with a pseudolymphoma syndrome due to carbamazepine." | 7.70 | Pseudolymphoma syndrome due to carbamazepine. ( Etoh, T; Mihm, MC; Saeki, H; Toda, K, 1999) |
| "We have described the case of a patient who had symptoms of the neuroleptic malignant syndrome after treatment with carbamazepine." | 7.68 | Neuroleptic malignant syndrome associated with carbamazepine. ( O'Griofa, FM; Voris, JC, 1991) |
| "One schizophrenic and two manic-depressive patients who after the administration of zotepine, a new antipsychotic and antimanic drug, developed alopecia areata, a kind of autoimmune disease, are reported." | 7.68 | Three cases of alopecia areata induced by zotepine. ( Ishikura, T; Jibiki, I; Kubota, T, 1993) |
| "A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression." | 7.67 | Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. ( Luchins, DJ, 1984) |
| "Carbamazepine was administered in a double-blind trial and therapeutic effects were measured by the Scale for the Assessment of Negative Symptoms (SANS)." | 6.67 | A double-blind trial of carbamazepine in negative symptom schizophrenia. ( Kritz, A; Levin, Y; Levy, A; Nachshoni, T; Neumann, M, 1994) |
| "Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks." | 6.66 | A carbamazepine trial in chronic, treatment-refractory schizophrenia. ( Costa, J; Heh, C; Herrera, J; Simpson, G; Sramek, J; Tran-Johnson, T, 1988) |
| "Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole were studied in 18 inpatients with schizophrenia being treated with aripiprazole." | 5.14 | Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia. ( Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Suzuki, T, 2009) |
| "The objective of this study was to assess the pharmacokinetics of aripiprazole when coadministered with carbamazepine using an open-label sequential treatment design in patients with schizophrenia or schizoaffective disorder." | 5.12 | Pharmacokinetics of aripiprazole and concomitant carbamazepine. ( Boulton, DW; Citrome, L; Macher, JP; Mallikaarjun, S; Salazar, DE, 2007) |
| "Based on currently available randomised trial-derived evidence, carbamazepine cannot be recommended for routine clinical use for treatment or augmentation of antipsychotic treatment of schizophrenia." | 4.90 | Carbamazepine for schizophrenia. ( Dold, M; Helfer, B; Kissling, W; Leucht, S; McGrath, J, 2014) |
| "To evaluate the effects of carbamazepine and its derivatives for the treatment of schizophrenia and related psychoses." | 4.84 | Carbamazepine for schizophrenia. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2007) |
| "This article is based upon a review of relevant literature on treatment with the mood stabilizers lithium, carbamazepine, valproate and lamotrigine in patients with schizophrenia." | 4.82 | [Are mood stabilizers beneficial in the treatment of schizophrenia?]. ( Berle, JØ; Spigset, O, 2005) |
| "Based on currently available evidence from randomised trials, carbamazepine cannot be recommend for routine clinical use for sole treatment, or augmentation of antipsychotic treatment, of schizophrenia." | 4.81 | Carbamazepine for schizophrenia and schizoaffective psychoses. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2002) |
| "Randomized controlled trials comparing carbamazepine (as a sole or as an adjunctive compound) with placebo or no intervention in participants with schizophrenia or schizoaffective disorder were searched for by accessing 7 electronic databases, cross-referencing publications cited in pertinent studies, and contacting drug companies that manufacture carbamazepine." | 4.81 | Carbamazepine augmentation for schizophrenia: how good is the evidence? ( Kissling, W; Leucht, S; McGrath, J; White, P, 2002) |
| "Based on currently available randomised trial-derived evidence, carbamazepine cannot be recommend for routine clinical use for treatment or augmentation of antipsychotic treatment of schizophrenia." | 4.80 | Carbamazepine for schizophrenia and schizoaffective psychoses. ( Kissling, W; Leucht, S; McGrath, J; White, P, 2000) |
| " In the field of antipsychotics, the first clinical trial on haloperidol decanoate in the treatment of schizophrenia was performed and the daily changes of blood concentrations of haloperidol were also observed." | 4.76 | [Recent advances in clinical psychopharmacology]. ( Mori, A, 1984) |
| "We found increased risks of cataract development in long-term users of lithium, lithium combined with other MS and valproic acid combined with other MS for more than two years among patients with BD and schizophrenia." | 3.88 | Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study. ( Chou, PH; Chu, CS; Lan, TH; Lin, CH, 2018) |
| "We report the case of a 61-year-old man with schizophrenia who was treated with carbamazepine, in whom electrocardiography showed transient Brugada-type ST elevation." | 3.85 | A Carbamazepine-induced Brugada-type Electrocardiographic Pattern in a Patient with Schizophrenia. ( Hasebe, N; Kawamura, Y; Ota, H; Sato, N, 2017) |
| "A 53-year-old female patient with schizophrenia and hypertension was on paliperidone 12 mg/day and amlodipine 5 mg/day." | 3.81 | Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine. ( Akamine, Y; Miura, M; Uehara, H; Uno, T; Yasui-Furukori, N, 2015) |
| "Given the potential concomitant use of carbamazepine and paliperidone extended-release (ER) in the treatment of schizophrenia or schizoaffective disorder, this open-label, two-treatment sequential study investigated the effect of repeated administration of carbamazepine on the steady-state pharmacokinetics of paliperidone." | 3.80 | Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state. ( Berwaerts, J; Cleton, A; Kerbusch-Herben, V; Remmerie, B; Vandebosch, A, 2014) |
| "This study investigated the effects of three AEDs (carbamazepine, oxcarbazepine, and valproic acid) on nicotine and nicotine metabolite levels in 149 smokers with schizophrenia and bipolar disorder who participated in an afternoon blood draw for nicotine, cotinine, and 3'-hydroxycotinine (3HC)." | 3.76 | Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness. ( Benowitz, NL; Gandhi, KK; Williams, JM, 2010) |
| " Perazine in combination with carbamazepine has shown satisfying results in several single-schizophrenia patients, leading to the hypothesis of being equal or even superior to atypical antipsychotic monotherapy." | 3.74 | Perazine and carbamazepine in comparison to olanzapine in schizophrenia. ( Emrich, HM; Godecke-Koch, T; Hoffmann, J; Jahn, K; Ohlmeier, MD; Schneider, U; Seifert, J; Wilhelm-Gossling, C, 2007) |
| "An autopsy case of carbamazepine overdose with focal myocarditis is reported." | 3.73 | A case of carbamazepine overdose with focal myocarditis. ( Aoki, Y; Niitsu, H; Saigusa, K; Takamiya, M, 2006) |
| "The efficacy of an adjuvant application of carbamazepine in cannabis-related schizophrenia-like psychosis not responsive to neuroleptic treatment is reported for the first time." | 3.70 | Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse. ( Emrich, HM; Leweke, FM, 1999) |
| "day-1), carbamazepine, levomepromazine and alprazolan, a severe shock with bradycardia (HR: 40 b." | 3.70 | [Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon]. ( Joye, F; Marion, F; Michoux, I; Orrillard, M; Parisot, R, 1999) |
| "The study describes changes over time in the adjunctive use of valproate and other mood stabilizers-lithium, carbamazepine, and gabapentin--among hospitalized psychiatric patients with a diagnosis of schizophrenia." | 3.70 | Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998. ( Allingham, B; Citrome, L; Levine, J, 2000) |
| "We described a 29-year-old Japanese woman with a pseudolymphoma syndrome due to carbamazepine." | 3.70 | Pseudolymphoma syndrome due to carbamazepine. ( Etoh, T; Mihm, MC; Saeki, H; Toda, K, 1999) |
| "One schizophrenic and two manic-depressive patients who after the administration of zotepine, a new antipsychotic and antimanic drug, developed alopecia areata, a kind of autoimmune disease, are reported." | 3.68 | Three cases of alopecia areata induced by zotepine. ( Ishikura, T; Jibiki, I; Kubota, T, 1993) |
| "We have described the case of a patient who had symptoms of the neuroleptic malignant syndrome after treatment with carbamazepine." | 3.68 | Neuroleptic malignant syndrome associated with carbamazepine. ( O'Griofa, FM; Voris, JC, 1991) |
| "A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression." | 3.67 | Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. ( Luchins, DJ, 1984) |
| "The therapeutic effects of carbamazepine (CBZ) were evaluated in 103 patients with affective disorders, 54 with schizophrenic disorders, and 26 with schizoaffective disorders by a multi-institutional open study." | 3.67 | Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders. ( Hazama, H; Inanaga, K; Itoh, H; Kurihara, M; Okuma, T; Otsuki, S; Sarai, K; Takahashi, R; Watanabe, S; Yamashita, I, 1989) |
| "Carbamazepine is now used by many clinicians in the treatment of bipolar disorder (BD) refractory to standard treatments, including lithium and neuroleptics." | 3.67 | Long-term response to carbamazepine: a retrospective study. ( Cohen, BM; Frankenburg, FR; Lipinski, JF; Tohen, M, 1988) |
| "Carbamazepine was administered in a double-blind trial and therapeutic effects were measured by the Scale for the Assessment of Negative Symptoms (SANS)." | 2.67 | A double-blind trial of carbamazepine in negative symptom schizophrenia. ( Kritz, A; Levin, Y; Levy, A; Nachshoni, T; Neumann, M, 1994) |
| "Relapse was determined by the concordance of psychiatric ratings and independent clinical judgements indicating significant worsening." | 2.67 | Carbamazepine maintenance treatment in outpatient schizophrenics. ( Breier, A; Buchanan, RW; Carpenter, WT; Hanlon, TE; Kirkpatrick, B; Kurz, R; Summerfelt, AT; Waltrip, RW, 1991) |
| "Carbamazepine was given to 12 chronic, treatment-refractory schizophrenic patients for 5 weeks." | 2.66 | A carbamazepine trial in chronic, treatment-refractory schizophrenia. ( Costa, J; Heh, C; Herrera, J; Simpson, G; Sramek, J; Tran-Johnson, T, 1988) |
| "Carbamazepine has recently been reported to have therapeutic potential in mania." | 2.65 | Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. ( Belmaker, RH; Bental, E; Klein, E; Lerer, B, 1984) |
| " Vegetative and neurotoxic effects most commonly occur in the beginning of therapy, after increasing the dosage and in case of intoxication." | 2.38 | [Carbamazepine in the treatment of psychiatric diseases: effects and side effects]. ( Rittmannsberger, H, 1990) |
| " On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder." | 1.35 | Transcription factor SP4 is a susceptibility gene for bipolar disorder. ( Geyer, MA; Greenwood, TA; Guo, S; He, L; Kelsoe, JR; Tang, W; Zhou, X, 2009) |
| "Carbamazepine 400 mg." | 1.30 | Interaction between carbamazepine and bromperidol. ( Furukori, H; Inoue, Y; Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Yasui, N, 1997) |
| "Clozapine can induce dose-dependent myoclonus." | 1.29 | Myoclonus in patients treated with clozapine: a case series. ( Bak, TH; Bauer, M; Hellweg, R; Reischies, FM; Schaub, RT, 1995) |
| " In this case, it seems necessary to diminish the interval between injections than to give higher dosage in order to maintain plasma concentrations." | 1.29 | Do enzyme inducers modify haloperidol decanoate rate of release? ( Agenet, C; Barges-Bertocchio, MH; Levron, JC; Pupeschi, G, 1994) |
| " Neither dosage nor serum levels of CBZ were in a higher range." | 1.28 | Asterixis induced by carbamazepine therapy. ( Leblhuber, F; Rittmannsberger, H, 1992) |
| " Neuroleptic medications are still the mainstay of treatment, but recent studies suggest new approaches to dosage and to the treatment of acute psychosis." | 1.27 | The pharmacologic treatment of schizophrenia: a progress report. ( Baldessarini, RJ; Donaldson, SR; Gelenberg, AJ, 1983) |
| "Carbamazepine was given to five patients with mixed frontal lobe disease and a variety of primary psychiatric disorders." | 1.27 | Carbamazepine in mixed frontal lobe and psychiatric disorders. ( McAllister, TW, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (38.73) | 18.7374 |
| 1990's | 46 (32.39) | 18.2507 |
| 2000's | 27 (19.01) | 29.6817 |
| 2010's | 12 (8.45) | 24.3611 |
| 2020's | 2 (1.41) | 2.80 |
| Authors | Studies |
|---|---|
| Socco, S | 1 |
| Jhawar, A | 1 |
| Riddle, MA | 1 |
| Puranen, A | 1 |
| Koponen, M | 1 |
| Lähteenvuo, M | 1 |
| Tanskanen, A | 1 |
| Tiihonen, J | 1 |
| Taipale, H | 1 |
| Chu, CS | 1 |
| Lin, CH | 1 |
| Lan, TH | 1 |
| Chou, PH | 1 |
| Ota, H | 1 |
| Kawamura, Y | 1 |
| Sato, N | 1 |
| Hasebe, N | 1 |
| Yasui-Furukori, N | 4 |
| Kubo, K | 1 |
| Ishioka, M | 1 |
| Tsuchimine, S | 1 |
| Inoue, Y | 3 |
| Leucht, S | 5 |
| Helfer, B | 1 |
| Dold, M | 1 |
| Kissling, W | 6 |
| McGrath, J | 5 |
| Akamine, Y | 1 |
| Uehara, H | 1 |
| Miura, M | 1 |
| Uno, T | 1 |
| Kerbusch-Herben, V | 1 |
| Cleton, A | 1 |
| Berwaerts, J | 1 |
| Vandebosch, A | 1 |
| Remmerie, B | 1 |
| Meyer, JM | 1 |
| Cummings, MA | 1 |
| Proctor, G | 1 |
| Stahl, SM | 2 |
| Zhou, X | 1 |
| Tang, W | 1 |
| Greenwood, TA | 1 |
| Guo, S | 1 |
| He, L | 1 |
| Geyer, MA | 1 |
| Kelsoe, JR | 1 |
| Nakamura, A | 1 |
| Mihara, K | 4 |
| Nagai, G | 1 |
| Suzuki, T | 2 |
| Kondo, T | 4 |
| Williams, JM | 1 |
| Gandhi, KK | 1 |
| Benowitz, NL | 1 |
| Levin, R | 1 |
| Calzavara, MB | 1 |
| Santos, CM | 1 |
| Medrano, WA | 1 |
| Niigaki, ST | 1 |
| Abílio, VC | 1 |
| Gazdag, G | 1 |
| Takács, R | 1 |
| Ungvari, GS | 1 |
| Huang, LY | 2 |
| Lin, CM | 1 |
| Chiou, CC | 2 |
| Lin, WS | 1 |
| Cheng, SM | 1 |
| Cohen, D | 1 |
| Loonen, AJ | 1 |
| White, P | 4 |
| Hosák, L | 1 |
| Libiger, J | 1 |
| Baird, P | 1 |
| Suzuki, A | 3 |
| Kaneko, S | 3 |
| Ogihara, T | 1 |
| Takahashi, T | 1 |
| Hanihara, T | 1 |
| Amano, N | 1 |
| Matsumoto, K | 1 |
| Leweke, FM | 2 |
| Gerth, CW | 1 |
| Koethe, D | 1 |
| Faulhaber, J | 1 |
| Klosterkotter, J | 1 |
| Heveling, T | 1 |
| Emrich, HM | 5 |
| Dietrich, DE | 1 |
| Berle, JØ | 1 |
| Spigset, O | 3 |
| Takamiya, M | 1 |
| Aoki, Y | 1 |
| Niitsu, H | 1 |
| Saigusa, K | 1 |
| Kilbourne, AM | 1 |
| Post, EP | 1 |
| Bauer, MS | 1 |
| Zeber, JE | 1 |
| Copeland, LA | 1 |
| Good, CB | 1 |
| Pincus, HA | 1 |
| Citrome, L | 2 |
| Macher, JP | 1 |
| Salazar, DE | 1 |
| Mallikaarjun, S | 1 |
| Boulton, DW | 1 |
| Helland, A | 1 |
| Chen, H | 1 |
| Kennedy, WK | 1 |
| Dorfman, JH | 1 |
| Fincham, JE | 1 |
| Reeves, J | 1 |
| Martin, BC | 1 |
| Ohlmeier, MD | 1 |
| Jahn, K | 1 |
| Wilhelm-Gossling, C | 1 |
| Godecke-Koch, T | 1 |
| Hoffmann, J | 1 |
| Seifert, J | 1 |
| Schneider, U | 1 |
| Liao, WC | 1 |
| Lou, JP | 1 |
| Hu, P | 1 |
| Ko, FC | 1 |
| Hakola, HP | 1 |
| Laulumaa, VA | 1 |
| Neppe, VM | 4 |
| Stoudemire, A | 1 |
| Nelson, A | 1 |
| Houpt, JL | 1 |
| Hertrich, O | 1 |
| Donaldson, SR | 1 |
| Gelenberg, AJ | 1 |
| Baldessarini, RJ | 1 |
| Mori, A | 1 |
| Staughton, RC | 1 |
| Payne, CM | 1 |
| Harper, JI | 1 |
| McMichen, H | 1 |
| Vaddadi, KS | 1 |
| Monroe, RR | 1 |
| Klein, E | 2 |
| Bental, E | 1 |
| Lerer, B | 1 |
| Belmaker, RH | 2 |
| Post, RM | 3 |
| Uhde, TW | 1 |
| Wolff, EA | 1 |
| Ballenger, JC | 1 |
| Altmann, H | 1 |
| Dose, M | 2 |
| von Zerssen, D | 1 |
| Kuehnle, JC | 1 |
| Joseph, AB | 1 |
| Anderson, WH | 1 |
| Luchins, DJ | 2 |
| Privitera, MR | 1 |
| Greden, JF | 1 |
| Gardner, RW | 1 |
| Ritchie, JC | 1 |
| Carroll, BJ | 1 |
| Okuma, T | 3 |
| Silberman, EK | 1 |
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Bak, TH | 1 |
| Bauer, M | 1 |
| Schaub, RT | 1 |
| Hellweg, R | 1 |
| Reischies, FM | 1 |
| Vieweg, V | 1 |
| Pandurangi, A | 1 |
| Levenson, J | 1 |
| Silverman, J | 1 |
| Pupeschi, G | 1 |
| Agenet, C | 1 |
| Levron, JC | 1 |
| Barges-Bertocchio, MH | 1 |
| Kubota, T | 1 |
| Ishikura, T | 1 |
| Jibiki, I | 1 |
| Vanelle, JM | 1 |
| Nachshoni, T | 1 |
| Levin, Y | 1 |
| Levy, A | 1 |
| Kritz, A | 1 |
| Neumann, M | 1 |
| Matsuura, M | 1 |
| Yoshino, M | 1 |
| Ohta, K | 1 |
| Onda, H | 1 |
| Nakajima, K | 1 |
| Kojima, T | 1 |
| Carleborg, L | 1 |
| Mjörndal, T | 1 |
| Norström, A | 1 |
| Sundgren, M | 1 |
| Wolkowitz, OM | 1 |
| Raitasuo, V | 1 |
| Lehtovaara, R | 1 |
| Huttunen, MO | 1 |
| Iwahashi, K | 3 |
| Nakamura, K | 1 |
| Miyatake, R | 2 |
| Suwaki, H | 2 |
| Hosokawa, K | 2 |
| Ichikawa, Y | 1 |
| Simhandl, C | 1 |
| Meszaros, K | 1 |
| Denk, E | 1 |
| Thau, K | 1 |
| Topitz, A | 1 |
| Barnes, TR | 2 |
| McEvedy, CJ | 1 |
| McDonald, WM | 1 |
| Nemeroff, CB | 1 |
| Harvey, CA | 1 |
| Norman, RM | 1 |
| Malla, AK | 1 |
| Cortese, L | 1 |
| Diaz, F | 1 |
| Otani, K | 1 |
| Ishida, M | 1 |
| Yasui, N | 1 |
| Furukori, H | 2 |
| Galletly, CA | 1 |
| Tsourtos, G | 1 |
| de Leon, J | 1 |
| Bork, J | 1 |
| Hesslinger, B | 2 |
| Klose, P | 2 |
| Normann, C | 2 |
| Langosch, JM | 2 |
| Berger, M | 2 |
| Walden, J | 2 |
| Hirokane, G | 1 |
| Someya, T | 1 |
| Takahashi, S | 1 |
| Morita, S | 1 |
| Shimoda, K | 1 |
| Kane, JM | 1 |
| Saeki, H | 1 |
| Etoh, T | 1 |
| Toda, K | 1 |
| Mihm, MC | 1 |
| Joye, F | 1 |
| Orrillard, M | 1 |
| Marion, F | 1 |
| Michoux, I | 1 |
| Parisot, R | 1 |
| Alfaro, CL | 1 |
| Nicolson, R | 1 |
| Lenane, M | 1 |
| Rapoport, JL | 1 |
| Levine, J | 1 |
| Allingham, B | 1 |
| Spina, E | 1 |
| Scordo, MG | 1 |
| Avenoso, A | 1 |
| Perucca, E | 1 |
| Hardy-Baylé, MC | 1 |
| Ono, S | 1 |
| de Vries, R | 1 |
| Brieden, T | 1 |
| Ujeyl, M | 1 |
| Naber, D | 1 |
| Franks, RD | 1 |
| Richter, AJ | 1 |
| Trimble, MR | 1 |
| Reynolds, EH | 1 |
| Rodin, EA | 1 |
| Rittmannsberger, H | 3 |
| Leblhuber, F | 2 |
| Liukkonen, J | 1 |
| Koponen, HJ | 1 |
| Nousiainen, U | 1 |
| Uehlinger, C | 1 |
| Barrelet, L | 1 |
| Touabi, M | 1 |
| Baumann, P | 1 |
| Karper, LP | 1 |
| Seibyl, JP | 1 |
| Krystal, JH | 1 |
| Koizumi, J | 1 |
| Moroji, T | 1 |
| Shiraishi, H | 1 |
| Hori, T | 1 |
| Baba, A | 1 |
| Kawai, N | 1 |
| Tada, K | 1 |
| Carpenter, WT | 1 |
| Kurz, R | 1 |
| Kirkpatrick, B | 1 |
| Hanlon, TE | 1 |
| Summerfelt, AT | 1 |
| Buchanan, RW | 1 |
| Waltrip, RW | 1 |
| Breier, A | 1 |
| Sommer, R | 1 |
| Gerson, SL | 1 |
| Lieberman, JA | 1 |
| Friedenberg, WR | 1 |
| Lee, D | 1 |
| Marx, JJ | 1 |
| Meltzer, H | 1 |
| Christison, GW | 1 |
| Kirch, DG | 1 |
| Wyatt, RJ | 1 |
| O'Griofa, FM | 1 |
| Voris, JC | 1 |
| Sultan, S | 1 |
| Chouinard, G | 2 |
| Beaudry, P | 1 |
| Báguena, F | 1 |
| Sánchez, P | 1 |
| Sánchez, C | 1 |
| Garau, J | 1 |
| Kahn, EM | 1 |
| Schulz, SC | 1 |
| Perel, JM | 1 |
| Alexander, JE | 1 |
| Diedrich, U | 1 |
| Müller, P | 1 |
| Kostiukova, EG | 1 |
| Yamashita, I | 2 |
| Takahashi, R | 2 |
| Itoh, H | 2 |
| Otsuki, S | 2 |
| Watanabe, S | 2 |
| Sarai, K | 2 |
| Hazama, H | 2 |
| Inanaga, K | 2 |
| Scher, M | 1 |
| Neppe, V | 1 |
| Svestka, J | 1 |
| Cesková, E | 1 |
| Rysánek, R | 1 |
| Náhunek, K | 1 |
| Tran-Johnson, T | 3 |
| Sramek, JJ | 3 |
| Walker, NR | 1 |
| Heh, CD | 1 |
| Costa, JF | 4 |
| Herrera, JM | 4 |
| Möller, HJ | 1 |
| Riehl, T | 1 |
| Bäuml, J | 1 |
| Binz, U | 1 |
| Wendt, G | 1 |
| Kurihara, M | 1 |
| Ortiz, A | 1 |
| Gershon, S | 1 |
| Heh, CW | 2 |
| Sramek, J | 4 |
| Herrera, J | 3 |
| Costa, J | 3 |
| Potkin, SG | 1 |
| Pickar, D | 1 |
| DeMet, E | 1 |
| Evans, RW | 1 |
| Gualtieri, CT | 1 |
| Heh, C | 3 |
| Tram-Johnson, T | 1 |
| Zhao, GF | 1 |
| Simpson, G | 1 |
| Wetterling, T | 1 |
| Lykke, J | 1 |
| Magelund, CG | 1 |
| Schmidt, S | 1 |
| Greil, W | 1 |
| Apelt, S | 1 |
| Frankenburg, FR | 1 |
| Tohen, M | 1 |
| Cohen, BM | 1 |
| Lipinski, JF | 1 |
| Vovin, RIa | 1 |
| Skorik, AI | 1 |
| Aksenova, IO | 1 |
| Digilov, AG | 1 |
| Firulev, AA | 1 |
| Pi, E | 1 |
| Gadish, DB | 1 |
| Kidron, R | 1 |
| Averbuch, I | 1 |
| Jann, MW | 1 |
| Ereshefsky, L | 1 |
| Saklad, SR | 1 |
| Seidel, DR | 1 |
| Davis, CM | 1 |
| Burch, NR | 1 |
| Bowden, CL | 1 |
| McAllister, TW | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Fröbärj, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nicotine Intake in Smokers With Schizophrenia[NCT00382915] | 276 participants (Actual) | Observational | 2006-10-31 | Completed | |||
| Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial[NCT02235064] | 2 participants (Actual) | Interventional | 2014-07-31 | Terminated (stopped due to Low recruitment, completion of funding cycle) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Antidepressant Side-Effect Checklist (ASEC) was employed to detect any adverse reaction to treatment regimens (NCT02235064)
Timeframe: Discharge from hospital to 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 1 |
"Patients met with single psychiatrist (co-investigator), blinded to group assignment, who evaluated the patient using Edinburgh Postpartum Depression Screen, Hamilton Depression Rating Scale, Global Assessment of Functioning Scale, and clinical assessment~0 = No postpartum depression up to 12 weeks following discharge from hospital~1 = Postpartum depression up to 12 weeks following discharge from hospital" (NCT02235064)
Timeframe: Discharge from hospital to 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Participants (Count of Participants) |
|---|---|
| Sertraline | 0 |
| Placebo | 0 |
(NCT02235064)
Timeframe: 12 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 5301 |
| Placebo | 4734 |
(NCT02235064)
Timeframe: 4 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 3033 |
| Placebo | 2750 |
(NCT02235064)
Timeframe: 8 weeks postpartum
| Intervention | Grams (Mean) |
|---|---|
| Sertraline | 5301 |
| Placebo | 3685 |
29 reviews available for carbamazepine and Schizophrenia
| Article | Year |
|---|---|
Carbamazepine for schizophrenia.
Topics: Antimanic Agents; Antipsychotic Agents; Carbamazepine; Combined Modality Therapy; Humans; Randomized | 2014 |
Psychopharmacology of Persistent Violence and Aggression.
Topics: Aggression; Antimanic Agents; Antipsychotic Agents; Brain Injuries, Traumatic; Carbamazepine; Clozap | 2016 |
[The optimal combination of ECT with pharmacotherapy].
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tric | 2011 |
Carbamazepine for schizophrenia and schizoaffective psychoses.
Topics: Antimanic Agents; Carbamazepine; Humans; Schizophrenia | 2002 |
Antiepileptic drugs in schizophrenia: a review.
Topics: Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Resistance; Humans; Lamotrigine; Receptor | 2002 |
[Are mood stabilizers beneficial in the treatment of schizophrenia?].
Topics: Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; | 2005 |
Carbamazepine for schizophrenia.
Topics: Antimanic Agents; Carbamazepine; Humans; Randomized Controlled Trials as Topic; Schizophrenia | 2007 |
Fatal toxic epidermal necrolysis induced by carbamazepine treatment in a patient who previously had carbamazepine-induced Stevens-Johnson syndrome.
Topics: Adult; Carbamazepine; Fatal Outcome; Humans; Male; Schizophrenia; Stevens-Johnson Syndrome | 2007 |
ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Breast Feed | 2008 |
Interictal schizophrenia-like psychoses in temporal lobe epilepsy.
Topics: Anticonvulsants; Brain; Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Functional L | 1983 |
[Recent advances in clinical psychopharmacology].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzamides; Carbamazepine; Dyskine | 1984 |
Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses.
Topics: Adult; Aged; Alcoholism; Animals; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Mid | 1984 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia.
Topics: Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Antipsychotic Agents; Carbamazepine; Cognit | 1994 |
[Resistant schizophrenia: what chemotherapy?].
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Carbam | 1993 |
Rational polypharmacy in schizophrenia.
Topics: Antidepressive Agents; Benzodiazepines; Carbamazepine; Combined Modality Therapy; Drug Therapy, Comb | 1993 |
Pharmacological treatment strategies in the non-responsive schizophrenic patient.
Topics: Antipsychotic Agents; Benzodiazepines; Carbamazepine; Humans; Lithium; Schizophrenia; Treatment Fail | 1996 |
The diagnosis and treatment of mania in the elderly.
Topics: Age of Onset; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Diagnosis, Differential; Dose- | 1996 |
[Adjuvant treatment of schizophrenic illness with carbamazepine].
Topics: Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Interactions; Humans; Schizophrenia | 1998 |
Tardive dyskinesia in affective disorders.
Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipol | 1999 |
Carbamazepine for schizophrenia and schizoaffective psychoses.
Topics: Antimanic Agents; Carbamazepine; Humans; Schizophrenia | 2000 |
Carbamazepine augmentation for schizophrenia: how good is the evidence?
Topics: Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Cross-Over Studies; Drug The | 2002 |
Psychopharmacological treatment of aggression in schizophrenic patients.
Topics: Adrenergic beta-Antagonists; Aggression; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Ca | 2002 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind M | 1991 |
[Carbamazepine in the treatment of psychiatric diseases: effects and side effects].
Topics: Affective Disorders, Psychotic; Aggression; Alcoholism; Carbamazepine; Humans; Mental Disorders; Psy | 1990 |
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinica | 1986 |
Carbamazepine: a neuropsychological and psychiatric profile.
Topics: Adolescent; Adult; Attention; Blood Proteins; Carbamazepine; Child; Cognition; Epilepsy; Female; Hum | 1985 |
Carbamazepine in nonresponsive psychosis.
Topics: Carbamazepine; Chronic Disease; Clinical Trials as Topic; Humans; Psychotic Disorders; Schizophrenia | 1988 |
[Carbamazepine in the treatment of psychiatric diseases. Review of the current status of research].
Topics: Affective Disorders, Psychotic; Carbamazepine; Humans; Schizophrenia | 1987 |
27 trials available for carbamazepine and Schizophrenia
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic interactions between carbamazepine and aripiprazole in patients with schizophrenia.
Topics: Antimanic Agents; Aripiprazole; Carbamazepine; Drug Interactions; Female; Humans; Male; Piperazines; | 2009 |
Oxcarbazepine as an adjunct for schizophrenia.
Topics: Acute Disease; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combinatio | 2004 |
Pharmacokinetics of aripiprazole and concomitant carbamazepine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Carbamazepine; Drug Antagonism; Drug The | 2007 |
Carbamazepine in the psychiatric patient.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Mental Di | 1982 |
Non-responsive psychosis--a biochemical difference?
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Method; Humans | 1983 |
Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities.
Topics: Adolescent; Adult; Carbamazepine; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; El | 1983 |
Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
Topics: Adult; Aged; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Th | 1984 |
Profile of clinical efficacy and side effect of carbamazepine in psychiatric illness: relationship to blood and CSF levels of carbamazepine and its -10,11-epoxide metabolite.
Topics: Biotransformation; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Depressive Disorder; D | 1984 |
Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses.
Topics: Adult; Aged; Alcoholism; Animals; Carbamazepine; Clinical Trials as Topic; Female; Humans; Male; Mid | 1984 |
Therapeutic effects of GABA-ergic drugs in affective disorders. A preliminary report.
Topics: Adolescent; Adult; Analgesics; Anticonvulsants; Bipolar Disorder; Carbamazepine; Clinical Trials as | 1983 |
A double-blind trial of carbamazepine in negative symptom schizophrenia.
Topics: Adult; Antipsychotic Agents; Arousal; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; | 1994 |
Adjunctive carbamazepine or lithium carbonate in therapy-resistant chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Female; | 1996 |
[Adjuvant treatment of schizophrenic illness with carbamazepine].
Topics: Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Interactions; Humans; Schizophrenia | 1998 |
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combi | 1999 |
Carbamazepine maintenance treatment in outpatient schizophrenics.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Carbamazepine; Double-Blind Method; Female; Humans; Ma | 1991 |
When symptoms persist: choosing among alternative somatic treatments for schizophrenia.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clozapine; Double-Blind M | 1991 |
Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Hal | 1990 |
A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Carbamazepine; Clinical Trials as Topic; Double-Blind | 1989 |
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Topics: Adult; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1989 |
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinica | 1986 |
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ga | 1988 |
Carbamazepine in nonresponsive psychosis.
Topics: Carbamazepine; Chronic Disease; Clinical Trials as Topic; Humans; Psychotic Disorders; Schizophrenia | 1988 |
A carbamazepine trial in chronic, treatment-refractory schizophrenia.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Humans; Male; Middle Aged; Psychiatric Status Rating | 1988 |
Open clinical trial of carbamazepine in chronic schizophrenic inpatients.
Topics: Adult; Carbamazepine; Chronic Disease; Clinical Trials as Topic; Humans; Male; Middle Aged; Psychiat | 1987 |
[Carbamazepine therapy of manic depressive psychosis and schizo-affective psychosis].
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Humans; Schizophrenia | 1987 |
Carbamazepine as an adjunct of antipsychotic therapy.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Biperiden; Carbamazepine; Chlorprothixene; Clinical Tria | 1987 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
91 other studies available for carbamazepine and Schizophrenia
| Article | Year |
|---|---|
The use of carbamazepine to expedite the metabolism of a long-acting aripiprazole injection.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Delayed-Action Preparations; Fem | 2022 |
Real-world effectiveness of mood stabilizer use in schizophrenia.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Female; Humans; Lamotrigine; | 2023 |
Associations between use of mood stabilizers and risk of cataract: A population-based nested case-control study.
Topics: Adult; Aged; Antimanic Agents; Bipolar Disorder; Carbamazepine; Case-Control Studies; Cataract; Data | 2018 |
A Carbamazepine-induced Brugada-type Electrocardiographic Pattern in a Patient with Schizophrenia.
Topics: Brugada Syndrome; Carbamazepine; Drug Therapy, Combination; Electrocardiography; Humans; Hypothyroid | 2017 |
Interaction between paliperidone and carbamazepine.
Topics: Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Humans; Isoxazoles; Palipe | 2013 |
Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine.
Topics: Amlodipine; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Pre | 2015 |
Effect of carbamazepine on the pharmacokinetics of paliperidone extended-release tablets at steady-state.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Area Under Curve; ATP Binding Cassette Transporter, S | 2014 |
Transcription factor SP4 is a susceptibility gene for bipolar disorder.
Topics: Adolescent; Adult; Animals; Antimanic Agents; Asian People; Bipolar Disorder; Carbamazepine; Case-Co | 2009 |
Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.
Topics: Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Bipolar Disorder; Carbamazepine; Cotinine; Cy | 2010 |
Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Carbamazepine; C | 2011 |
Rhabdomyolysis as a potential complication of carbamazepine-induced toxic epidermal necrolysis.
Topics: Adult; Antimanic Agents; Carbamazepine; Fatal Outcome; Humans; Male; Rhabdomyolysis; Schizophrenia; | 2012 |
Are immediate- and extended-release drugs interchangeable?
Topics: Antimanic Agents; Carbamazepine; Cost of Illness; Delayed-Action Preparations; Dosage Forms; Drug Su | 2013 |
The interactive metabolism effect of oxcarbazepine coadministered with tricyclic antidepressant therapy for OCD symptoms.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Humans; Male; M | 2003 |
Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
Topics: Adult; Aged; Analysis of Variance; Brief Psychiatric Rating Scale; Carbamazepine; Dose-Response Rela | 2003 |
Carbamazepine-induced hypersensitivity syndrome, associated with human herpesvirus 6 reactivation.
Topics: Adult; Carbamazepine; Drug Hypersensitivity; Female; Herpesvirus 6, Human; Humans; Psychomotor Agita | 2004 |
Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels.
Topics: Affect; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Drug Therapy, Combin | 2004 |
Treatment of a rare psychopathological phenomenon: tactile hallucinations and the delusional other.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Chronic Disease; Delusions; Drug Therapy | 2004 |
A case of carbamazepine overdose with focal myocarditis.
Topics: Adult; Antimanic Agents; Bipolar Disorder; Carbamazepine; Drug Overdose; Female; Humans; Lymphocytes | 2006 |
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Cardiovascular Diseases; Drug Monitori | 2007 |
Low serum concentrations of reboxetine in 2 patients treated with CYP3A4 inducers.
Topics: Adrenergic Uptake Inhibitors; Adult; Anticonvulsants; Bulimia Nervosa; Carbamazepine; Cytochrome P-4 | 2007 |
The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
Topics: Adult; Affect; Algorithms; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Chemotherapy, Adju | 2007 |
Perazine and carbamazepine in comparison to olanzapine in schizophrenia.
Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Drug Thera | 2007 |
Carbamazepine in treatment of violent schizophrenics.
Topics: Adult; Anger; Carbamazepine; Humans; Male; Middle Aged; Rage; Schizophrenia | 1982 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 2].
Topics: Bromazepam; Carbamazepine; Chlordiazepoxide; Chlorpromazine; Humans; Perphenazine; Psychophysiologic | 1983 |
The pharmacologic treatment of schizophrenia: a progress report.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Ca | 1983 |
Toxic pustuloderma--a new entity?
Topics: Adult; Carbamazepine; Dermatitis, Exfoliative; Drug Eruptions; Humans; Male; Schizophrenia; Suppurat | 1984 |
The use of gamma-linolenic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia.
Topics: Adult; Carbamazepine; Diagnosis, Differential; Electroencephalography; Epilepsy, Temporal Lobe; Fema | 1981 |
Limbic ictus and atypical psychoses.
Topics: Amphetamine; Animals; Carbamazepine; Cocaine; Electric Stimulation; Electroencephalography; Epilepsy | 1982 |
Carbamazepine in chronic patients with EEG abnormalities.
Topics: Carbamazepine; Electroencephalography; Epilepsy, Temporal Lobe; Humans; Schizophrenia | 1984 |
Carbamazepine in violent non-epileptic schizophrenics.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Schizophrenia | 1984 |
Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine.
Topics: Aggression; Agranulocytosis; Carbamazepine; Chronic Disease; Humans; Male; Middle Aged; Schizophreni | 1984 |
Interference by carbamazepine with the dexamethasone suppression test.
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dexamethasone; Diagnosis, D | 1982 |
Differential sensitivity to the effects of psychotropic drugs: psychotics vs normals; Asian vs Western populations.
Topics: Bipolar Disorder; Carbamazepine; Chlorpromazine; Cross-Cultural Comparison; Dose-Response Relationsh | 1981 |
The march of symptoms in a psychotic decompensation. Case report and theoretical implications.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Behavior; Carbamazepine; Chlorpromazine; Drug The | 1980 |
Myoclonus in patients treated with clozapine: a case series.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Clozapine; Depressive Disorder; Diagnosis, Differential; | 1995 |
Do enzyme inducers modify haloperidol decanoate rate of release?
Topics: Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Haloperido | 1994 |
Three cases of alopecia areata induced by zotepine.
Topics: Adult; Alopecia; Alopecia Areata; Antipsychotic Agents; Autoimmune Diseases; Carbamazepine; Clomipra | 1993 |
Clinical significance of diffuse delta EEG activity in chronic schizophrenia.
Topics: Antipsychotic Agents; Carbamazepine; Chronic Disease; Delta Rhythm; Female; Humans; Intelligence Tes | 1994 |
Carbamazepine interference in a high-performance liquid chromatography analysis for perphenazine.
Topics: Adult; Carbamazepine; Chromatography, High Pressure Liquid; Humans; Male; Perphenazine; Schizophreni | 1994 |
Carbamazepine and plasma levels of clozapine.
Topics: Adult; Carbamazepine; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Mal | 1993 |
Cardiac effects of haloperidol and carbamazepine treatment.
Topics: Carbamazepine; Electrocardiography; Haloperidol; Humans; Long QT Syndrome; Prevalence; Retrospective | 1996 |
The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.
Topics: Anticonvulsants; Antipsychotic Agents; Binding, Competitive; Carbamazepine; Cytochrome P-450 CYP2D6; | 1995 |
Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Electr | 1996 |
Psychomotor seizures presenting with hypnagogic visual hallucinations.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Craniocerebral Trauma; Epilepsy, Tempora | 1996 |
A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Humans; Middle Aged; Observer Variation; Psychiatric Sta | 1996 |
[Current knowledge on epilepsy, schizophrenia and spastic conditions. Neuro-Forum, Dresden, 5 April 1997].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsies, Partial; Epilepsy; Humans; Remission In | 1997 |
[Current knowledge on epilepsy, schizophrenia and spastic conditions. Neuro-Forum, Dresden, 5 April 1997].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsies, Partial; Epilepsy; Humans; Remission In | 1997 |
Interaction between carbamazepine and bromperidol.
Topics: Adult; Analgesics, Non-Narcotic; Antipsychotic Agents; Carbamazepine; Chromatography, High Pressure | 1997 |
Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia.
Topics: Adjuvants, Pharmaceutic; Adult; Ambulatory Care Facilities; Antiparkinson Agents; Antipsychotic Agen | 1997 |
Risperidone and cytochrome P450 3A.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme | 1997 |
Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
Topics: Aged; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Monitoring; Fem | 1999 |
Carbamazepine as an adjunct in the treatment of schizophrenia-like psychosis related to cannabis abuse.
Topics: Adult; Cannabis; Carbamazepine; Humans; Male; Psychotic Disorders; Schizophrenia; Time Factors | 1999 |
Pseudolymphoma syndrome due to carbamazepine.
Topics: Adult; Antimanic Agents; Blotting, Southern; Carbamazepine; Diagnosis, Differential; Facial Dermatos | 1999 |
[Severe intoxication probably from olanzapine (Zyprexa). Beneficial effect of glucagon].
Topics: Adult; Alprazolam; Antipsychotic Agents; Benzodiazepines; Bradycardia; Carbamazepine; Disseminated I | 1999 |
Carbamazepine and/or fluvoxamine drug interaction with risperidone in a patient on multiple psychotropic medications.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Carbamazepin | 2000 |
Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.
Topics: Acetates; Adult; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Cyc | 2000 |
Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Chronic Disease; Cytochrome P-450 CYP2 | 2001 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chl | 1998 |
Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes.
Topics: Adult; Carbamazepine; Cytochrome P-450 CYP2D6; Drug Interactions; Female; Genotype; Humans; Male; Mi | 2002 |
Schizophrenia-like psychosis associated with anticonvulsant toxicity.
Topics: Adult; Anticonvulsants; Athetosis; Carbamazepine; Chorea; Dose-Response Relationship, Drug; Drug The | 1979 |
Anticonvulsant drugs and mental symptoms: a review.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Folic Acid | 1976 |
Psychosocial management of patients with complex partial seizures.
Topics: Adult; Alcoholism; Carbamazepine; Delivery of Health Care; Drug Administration Schedule; Epilepsy; E | 1975 |
Asterixis induced by carbamazepine therapy.
Topics: Adult; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1992 |
Clinical picture and long-term course of epileptic seizures that occur during clozapine treatment.
Topics: Adult; Carbamazepine; Clonazepam; Clozapine; Electroencephalography; Epilepsies, Myoclonic; Epilepsy | 1992 |
Alopecia and mood stabilizers: two case reports.
Topics: Adult; Alopecia; Carbamazepine; Clorazepate Dipotassium; Depressive Disorder; Female; Fluvoxamine; H | 1992 |
Valproate management of psychosis in a patient with carbamazepine-induced hyponatremia.
Topics: Carbamazepine; Chronic Disease; Drinking; Drug Therapy, Combination; Humans; Hyponatremia; Male; Mid | 1992 |
Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics.
Topics: Adult; Anticonvulsants; Carbamazepine; Copper; Drug Therapy, Combination; Epilepsy, Generalized; Fem | 1992 |
Asterixis as a side effect of carbamazepine therapy.
Topics: Antipsychotic Agents; Carbamazepine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Ma | 1991 |
Polypharmacy in fatal clozapine-associated agranulocytosis.
Topics: Agranulocytosis; Carbamazepine; Clozapine; Humans; Male; Middle Aged; Monitoring, Physiologic; Schiz | 1991 |
Neuroleptic malignant syndrome associated with carbamazepine.
Topics: Carbamazepine; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Schizophrenia | 1991 |
Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Female; Humans; Male; Middle Aged; Phenytoin; Psychoses, | 1990 |
[Glucocorticoids and severe carbamazepine toxicity].
Topics: Acute Disease; Adult; Carbamazepine; Drug Hypersensitivity; Female; Glucocorticoids; Humans; Prednis | 1991 |
[Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
Topics: Adolescent; Carbamazepine; Clozapine; Diagnosis, Differential; Dose-Response Relationship, Drug; Dru | 1989 |
[Comparative features of the preventive action of carbamazepine and lithium carbonate in affective and schizoaffective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Depression; Drug Evaluation; | 1989 |
Carbamazepine adjunct for nonresponsive psychosis with prior hallucinogenic abuse.
Topics: Adult; Alcoholism; Antipsychotic Agents; Carbamazepine; Chlordiazepoxide; Drug Therapy, Combination; | 1989 |
Controlled cross-over comparison of carbamazepine with perphenazine in schizophrenic psychoses.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders; Perph | 1989 |
Effects of carbamazepine on serum calcium in schizophrenia.
Topics: Adolescent; Adult; Calcium; Carbamazepine; Humans; Male; Middle Aged; Schizophrenia | 1989 |
Clinical efficacy of carbamazepine in affective, schizoaffective, and schizophrenic disorders.
Topics: Adult; Carbamazepine; Female; Humans; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating S | 1989 |
Exacerbation of psychosis after discontinuation of carbamazepine treatment.
Topics: Adult; Antipsychotic Agents; Carbamazepine; Chronic Disease; Drug Therapy, Combination; Hospitalizat | 1988 |
Serum homovanillic acid concentrations in carbamazepine-treated chronic schizophrenics.
Topics: Adult; Carbamazepine; Chronic Disease; Homovanillic Acid; Humans; Male; Receptors, Dopamine; Schizop | 1989 |
The effect of carbamazepine on hematological hepatic function in chronic schizophrenia.
Topics: Adult; Blood; Carbamazepine; Chronic Disease; Humans; Liver; Male; Schizophrenia | 1988 |
[The use of carbamazepine in mental diseases].
Topics: Adolescent; Adult; Bipolar Disorder; Carbamazepine; Child; Female; Humans; Male; Middle Aged; Schizo | 1988 |
Long-term response to carbamazepine: a retrospective study.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Fem | 1988 |
[Effectiveness of finlepsin in the prophylactic therapy of phasic affective psychoses].
Topics: Adult; Affective Disorders, Psychotic; Bipolar Disorder; Carbamazepine; Chronic Disease; Drug Evalua | 1987 |
Time-dependent autoinduction of carbamazepine in schizophrenia.
Topics: Adult; Carbamazepine; Chronic Disease; Humans; Middle Aged; Schizophrenia | 1987 |
Hyponatremic effect of carbamazepine.
Topics: Adult; Carbamazepine; Humans; Hyponatremia; Male; Schizophrenia; Sodium; Water Intoxication | 1987 |
Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia.
Topics: Adult; Analysis of Variance; Carbamazepine; Chronic Disease; Depression; Humans; Irritable Mood; Mal | 1987 |
Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia.
Topics: Adult; Carbamazepine; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Schizophren | 1985 |
Effects of carbamazepine on plasma haloperidol levels.
Topics: Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Haloperidol; H | 1985 |
Carbamazepine in mixed frontal lobe and psychiatric disorders.
Topics: Aged; Brain Diseases; Carbamazepine; Frontal Lobe; Humans; Male; Mental Disorders; Middle Aged; Neur | 1985 |
[Carbamazepine--an antiepileptic agent with broad applicability, also in psychiatry. An introductory report with cases].
Topics: Adolescent; Adult; Carbamazepine; Diagnosis, Differential; Epilepsy; Female; Humans; Male; Neurotic | 1971 |